About the Authors
- Richard Stebbings
-
* E-mail: rstebbings@nibsc.ac.uk
Affiliation Division of Biotherapeutics, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom
- Michèle Février
-
Affiliation Unité de Génomique Virale et Vaccination, Institut Pasteur, Paris, France
- Bo Li
-
Affiliation Division of Biotherapeutics, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom
- Clarisse Lorin
-
Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium
- Marguerite Koutsoukos
-
Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium
- Edward Mee
-
Affiliation Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom
- Nicola Rose
-
Affiliation Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom
- Joanna Hall
-
Affiliation Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom
- Mark Page
-
Affiliation Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom
- Neil Almond
-
Affiliation Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom
- Gerald Voss
-
Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium
- Frédéric Tangy
-
Affiliation Unité de Génomique Virale et Vaccination, Institut Pasteur, Paris, France
Competing Interests
CL, MK and GV are employees of GlaxoSmithKline Vaccines. GlaxoSmithKline Biologicals partly funded this study. RS, MF, BL, EM, NR, JH MP and NA declare no competing interest. FT and CL are listed as “Inventor” of patents related to the measles vector vaccine, the rights of which have been assigned to the Institut Pasteur. Both authors do not hold a patent for the measles vector vaccine described in the present study. MK and GV own shares and/or options to shares in GSK. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: RS CL MP NA GV FT MK. Performed the experiments: MF BL EM NR JH MP. Analyzed the data: RS BL CL MK GV MP FT. Contributed reagents/materials/analysis tools: RS CL NR MP NA GV FT. Wrote the paper: RS BL CL FT.